Source: FinanzNachrichten

Valneva: Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ Among U.S. Travelers

Saint Herblain (France), April 18, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers...

Read full article »
Annual Revenue
$100-500M
Employees
500-1.0K
Thomas Lingelbach's photo - President & CEO of Valneva

President & CEO

Thomas Lingelbach

CEO Approval Rating

90/100

Read more